List of redirects
Jump to navigation
Jump to search
Showing below up to 50 results in range #33,331 to #33,380.
- MERSCOV → Middle East respiratory syndrome coronavirus infection
- MERS COV → Middle East respiratory syndrome coronavirus infection
- MERS CoV → Middle East respiratory syndrome coronavirus infection causes#Virology
- MERS CoV infection → Middle East respiratory syndrome coronavirus infection
- MERS Cov → Middle East respiratory syndrome coronavirus infection
- MERS coronavirus → Middle East respiratory syndrome coronavirus infection causes#Virology
- MERS cov → Middle East respiratory syndrome coronavirus infection
- MERS infection → Middle east respiratory syndrome coronavirus infection
- MERS virus → Middle East respiratory syndrome coronavirus infection causes#Virology
- METAFER → Use Of Metoprolol To Maintain Sinus Rhythm After Conversion From Persistent Atrial Fibrillation
- METEOR → Measuring Effects On Intima-Media Thickness: An Evaluation Of Rosuvastatin
- MEXIS → The Effects Of B-Receptor Antagonists In Patients With Clinical Evidence Of Heart Failure After Myocardial Infarction: Double Blind Comparison Of Meto
- MFP → Sodium monofluorophosphate
- MGAM → Maltase-glucoamylase
- MGUS → Monoclonal gammopathy of undetermined significance
- MGluR → Metabotropic glutamate receptor
- MGluR1 → Metabotropic glutamate receptor 1
- MGluR5 → Metabotropic glutamate receptor 5
- MH → Malignant hyperthermia
- MHA → Microangiopathic hemolytic anemia
- MHC Class I → MHC class I
- MHC Class II → MHC class II
- MHC I → MHC class I
- MHC II → MHC class II
- MHC II DM → HLA-DM
- MHC II DP → HLA-DP
- MHC II DQ → HLA-DQ
- MHC II DR → HLA-DR
- MHFT → Munich Mild Heart Failure Trial
- MHRA → Medicines and Healthcare products Regulatory Agency
- MHT → Hormone replacement therapy (menopause)
- MI → ST elevation myocardial infarction
- MIAMI → Metoprolol In Acute Myocardial Infarction
- MIC → Minimum inhibitory concentration
- MICRO-HOPE → Microalbuminuria, Cardiovascular, And Renal Outcomes - Heart Outcomes Prevention Evaluation
- MIDCAB → Minimally invasive direct coronary artery bypass surgery
- MILIS → Multiple Center Investigation Of The Limit Of Infarction
- MINT → A Multicenter, Randomized Study Of Argatroban Versus Heparin As Adjunct To Tissue Plasminogen Activator (Tpa) In Acute Myocardial Infarction: Myocardial Infarction With Novastan And Tpa (Mint) Study
- MIRACL → Effects Of Atorvastatin On Early Recurrent Ischemic Events In Acute Coronary Syndromes. The Miracl Study: A Randomized Controlled Trial
- MIRACLE ICD → Multicenter Insync Implantable Cardioversion Defibrillation Randomized Clinical Evaluation
- MISME Syndrome → Neurofibromatosis type II
- MIST → Migraine Intervention With Starflex Technology
- MITF → Microphthalmia-associated transcription factor
- MITI I → Myocardial Infarction Triage And Intervention Project--Phase I
- MITI II → Myocardial Infarction Triage And Intervention Project--Phase I
- MITRA → Maximal Individual Therapy In Acute Myocardial Infarction
- MITT → Intention to treat analysis
- MI and pregnancy → ST elevation myocardial infarction in pregnancy
- MI and pregnant → ST elevation myocardial infarction in pregnancy
- MI biomarkers → ST elevation myocardial infarction diagnostic criteria#Biomarkers in the Diagnosis of MI